731 Costs of care for first-line (1L) treatment of advanced non-small cell lung cancer (aNSCLC): a real-world claims analysis

• Jonathan Kish,
• Dhruv Chopra,
• Djibril Liassou,
• Solomon Lubinga,
• John Hartman,
• Bruce Feinberg

Affiliations

Jonathan Kish

1Cardinal Health, Dublin, OH, USA

Dhruv Chopra

1Cardinal Health, Dublin, OH, USA

Djibril Liassou

1Cardinal Health, Dublin, OH, USA

Solomon Lubinga

2Bristol Myers Squibb, Lawrenceville, NJ, USA

John Hartman

2Bristol Myers Squibb, Lawrenceville, NJ, USA

Bruce Feinberg

1Cardinal Health, Dublin, OH, USA